Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cell Biology
Findings from India, Germany and the South Korea in cell biology provide new insights
August 14th, 2006
Reports from India, Germany and the South Korea highlight recent research in cell biology. Study 1: A fludarabine-based regimen allows sustained engraftment without immediate toxicity. According to a study from India, "Multiply transfused patients of severe aplastic anemia are at increased risk of graft rejection. Five such patients underwent peripheral blood stem cell transplantation from HLA-identical siblings with a fludarabine-based protocol. "The conditioning consisted of fludarabine 30 mg/m2/day x 6 days, cyclophosphamide 60 mg/kg/day x 2 days and horse antithymocyte globulin (ATG) x 4 days. Two different ATG...
Source: Stem Cell Week (2006-08-14)
|
